Metformin ...They just didn't fully know why

 

Metformin

has been prescribed to hundreds of millions of people with type 2 diabetes for over 60 years.

Scientists knew it worked.

They just didn't fully know why.

Researchers at Baylor College of Medicine have now uncovered a major piece

of that puzzle:

the drug works directly on the brain, through a mechanism nobody

had identified before.

The discovery, published in Science Advances, centers on a small protein called Rap1 sitting inside a region of the brain called the ventromedial hypothalamus (VMH),

a control hub for whole-body metabolism.

When metformin reaches the VMH,

it effectively switches Rap1 off.

That, in turn, activates a specific cluster of neurons called SF1 neurons, which then signal the body to lower blood sugar.

When the team bred mice with no Rap1 in this brain region and put them on a high-fat diet, metformin completely stopped working.

Other diabetes drugs like insulin and GLP-1 agonists still worked fine, showing the brain pathway is unique to metformin.

One of the most striking findings was just how sensitive the brain is compared to the liver and gut.

The liver and intestines need high concentrations of the drug to respond.

The brain, on the other hand, reacted to doses thousands of times smaller than what is typically given orally.

This reframes six decades of medical understanding.

Metformin was never just

a liver drug or a gut drug.

It has been quietly acting

in the brain the whole time.

Researchers now plan to explore whether this same Rap1 brain pathway also explains metformin's other well-documented benefits, including slowing brain aging and its links to longer lifespan.

Human studies are still needed to confirm the mechanism, but the door is now open

to far more targeted diabetes therapies.